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Background: Both osteoporosis and osteopenia remain worldwide public health concerns. They 
both lead to bone fractures, which can lead to disability and burden on those who are afflicted.
Objectives: To assess and compare fracture risk between these two groups of patients.
Patients and methods: Our cross-sectional study included 82 patients (46 with osteoporosis 
and 36 with osteopenia) with an average age of 63±9.33 years, who received treatment at the 
Clinic for Medical Rehabilitation, Clinical Center of Vojvodina in Novi Sad, Serbia. The assess-
ment of the fracture risk was executed by applying the Fracture Assessment Risk (FRAX) index 
(an algorithm developed by the World Health Organization) based on clinical fracture risks or 
combination of clinical fracture risks and bone mineral density.
Results: Patients with osteoporosis had significantly higher risk of major fracture compared to 
patients with osteopenia (p<0.01). Results from FRAX index in osteoporotic patients showed that 
more than half (58.70%) of patients had a low risk of fracture; less than one-third of patients (30.43%) 
had an intermediate risk of major osteoporotic fracture, while almost four out of every 10 (39.96%) 
had a high risk of hip fracture. The majority of patients with osteopenia (63.89%) had a low risk 
of major osteoporotic fracture, while 36.11% of them had an intermediate risk. The majority of 
patients with osteopenia (91.67%) had a low risk of hip fracture. Statistically significant differences 
in relation to specific fracture risks between patients with osteoporosis and osteopenia, in particu-
lar, weight (t=−2.250, p=0.027*) and previous fractures (t=2.985, p=0.004**), were established.
Conclusion: Osteoporosis patients had a high risk of major osteoporotic fracture, while there 
was no association between the intermediate level for major osteoporotic fracture and osteo-
penia. For patients suffering from an increased fracture risk, especially those who had already 
been diagnosed with osteoporosis, preventive measures such as designing individual therapeutic 
programs should be adopted.
Keywords: osteoporosis, osteopenia, fracture risk, fractures, FRAX index, bone fracture, body 
mass index, bone mineral density
Introduction
Osteoporosis can be described as a skeletal disorder that is characterized by compro-
mised bone strength, which predisposes individuals to an increased risk of fracture.1 
Fractures due to osteoporosis may be defined as those that occur as a result of a low-
impact trauma, consequences of which range from chronic pain to institutionalization 
and death, due to complications.2–7 These types of fractures may cause compression of 
nerve roots and loss of height of few centimeters, which is a visible sign of the disease. 
With larger deformities, it is possible to have gastrointestinal discomforts and pain 
after the meal because of increased chest pressure over abdominal organs. Excessive 
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muscle and ligament burden on the spine causes chronic, 
blunt, and persistent pain, especially in the lower back area. 
Back pain is one of the most significant factors that usurps 
the quality of life among patients suffering from osteoporotic 
vertebral fractures.2,3
According to the World Health Organization (WHO), 
osteoporosis occurs when the bone mineral density (BMD) of 
an individual is ≥2.5 SDs below the young adult mean value 
(T-score, −2.5 or lower) among postmenopausal women as 
well as among men aged over 50 years. Kanis et al stated 
that if the BMD has a T-score of between −1 and −2.5, the 
disorder is classified as osteopenia.8 Although the most 
important determinant of fracture risk is low BMD, more 
than half of all low-trauma fractures occur among people 
with non-osteoporotic BMD (T-score > −2.5).9–12
The impact on decision about the treatment, beside the 
determination of BMD by dual-energy X-ray absorptiometry 
(DXA) method, has been through the assessment of prob-
ability of big osteoporotic fracture (spine, hip, forearm, 
upper arm) by using Fracture Assessment Risk (FRAX) 
index, which is a clinical instrument defined by Center for 
Metabolic Bone Disease of WHO (Sheffield, UK). By using 
FRAX index, it is possible to establish 10-year fracture risk, 
depending on the age, and life expectancy of clinical fracture 
risk.13,14 The introduction of FRAX index has assisted with 
the identification of patients of low, intermediate, and high 
fracture risks. For patients with intermediate fracture risk, 
some additional prevention measures are advised, such as 
measuring of femur density and reassessment of the risk.15
Women who live in a developed country and aged over 
50 years have about a 50% lifetime risk of sustaining a frac-
ture, while men in that category have a 20% lifetime risk.16 
Globally, a bone breaks because of osteoporosis every 3 
seconds; and in Europe, India, Japan, and the USA, there are 
an estimated 125 million people with the disease.17 According 
to a recent global report, the number of people living with 
osteoporosis is said to increase dramatically in the future, 
as a result of aging populations and changes in lifestyles.17
A recent study by Serbia18 found that out of 132 postmeno-
pausal women, about 59% had normal BMD, whereas 41% 
had osteoporosis or osteopenia. The study revealed that about 
one-third of the patients had a fracture, and the average num-
ber of fractures was 1.47 in all the women in the study. There 
has been extensive research on osteoporosis and osteopenia 
in Serbia.18–21 However, to the best of our knowledge, none 
of these studies has assessed the fracture risk factors associ-
ated with these two conditions, and a standardized FRAX 
questionnaire was not routinely applied in such assessments.
The purpose of this clinical research was to assess and 
compare the fracture risk among patients with osteoporosis 
and those suffering from osteopenia.
Patients and methods
A cross-sectional analysis was conducted on a group of 
patients with osteoporosis and others with osteopenia 
between April and August 2015. Patients who were already 
enrolled at the Clinic for Medical Rehabilitation (Clinical 
Centre of Vojvodina) in Novi Sad were invited to participate 
in this cross-sectional and comparative analysis. Measure-
ments were executed by DXA examination of lumbar spine 
and proximal femur using the Lunar Prodigy Primo device.
BMD for all patients was measured through DXA exami-
nation. T-value was used for diagnosing osteoporosis and 
osteopenia. Osteoporosis is defined as a value for BMD 2.5 SD 
or more below the young female adult mean (T-score ≤ −2.5 
SD). Severe osteoporosis (established osteoporosis) describes 
osteoporosis in the presence of one or more fragility fractures.22
In this study, we utilized a questionnaire to the partici-
pants face-to-face to obtain sociodemographic characteris-
tics, medical history, and fracture history, and 11 questions 
from FRAX survey to obtain BMD of femoral neck. FRAX 
is an algorithm developed by the WHO for predicting hip 
fracture or any other osteoporotic fracture (spine, forearm, 
shoulder) based on clinical risk factors or a combination of 
clinical risk factors and BMD. Data obtained from the ques-
tionnaire were inserted in a FRAX calculator, which yielded 
a 10-year-long risk for hip fracture and major osteoporotic 
fractures (MOFs; hip, vertebral, distal radius, and proximal 
humerus). By using this clinical instrument, and following the 
guidelines given by National Osteoporosis Guideline Group 
(NOGG), patients were divided into three different risk levels 
(low, intermediate, and high) for occurrence of MOFs and hip 
fractures as well.22 Ten-year risk for hip fracture was found to 
be higher by 3%, whereas for major fractures, it was higher 
by 20%, suggesting a treatment for such people.
Statistical analysis
We used the statistical program International Business 
Machines, SPSS version 22.0 (IBM Corporation, Armonk, 
NY, USA). Results were presented using standard statistical 
measures of central tendency and range of results. For estab-
lishing differences in results obtained on scales and subscales 
from which they were made of, Independent Sample t-test 
was used for testing the difference between the independent 
samples. Furthermore, only the variables with p-values ≤0.05 
were considered to be statistically significant.
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Ethical statement
Ethics approval from the Ethics Committee of the Clinical 
Center of Vojvodina in Novi Sad, Serbia, was obtained and 
all participants were enrolled in the study after signing the 
consent forms provided before entering the study.
Results
A total of 82 patients, 46 (7 men, 39 women) with osteo-
porosis and 36 (4 men and 32 women) with osteopenia, 
participated in this cross-sectional study. The average age 
of patients with osteoporosis was 66.34±10.23 years (range 
43–88 years), while the average age of patients with osteo-
penia was 62.44±7.63 years (range 48–81 years). Table 1 
presents the characteristics of all participants.
Statistically significant differences were established 
in representation of specific fracture risks between the 
patients with osteoporosis and osteopenia, in particular, 
weight (t=−2.250, p=0.05*) and previous fractures (t=2.985, 
p=0.01**; Table 2). Patients suffering from osteopenia had a 
significantly higher fracture risk compared to patients with 
osteoporosis, because of their weight, whereas patients suffer-
ing from osteoporosis had higher fracture risk in comparison 
to patients suffering from osteopenia, because of previous 
fractures (Table 2).
Through FRAX calculator, a 10-year fracture risk of hip 
fracture was confirmed among the patients with osteoporosis 
and osteopenia. Based on NOGG guidelines, patients were 
divided in to three risk levels (low, intermediate, and high) 
for MOF and hip fracture occurrence (Table 3).
The majority of patients (58.70%) had a low risk of MOF, 
less than one-third of patients had an intermediate risk, while 
10.87% had a high risk (Table 3).
With regard to hip fracture, the majority of patients with 
osteoporosis (56.52%) had low fracture risk, almost four 
out of every 10 (39.96%) had high risk, while 6.52% had 
intermediate risk (Table 3).
The highest number of patients with osteopenia had 
low risk level for MOF (23 [63.89%]), then intermediate 
(13 [36.11%]), while the patients with high risk were not 
accounted for (Table 4).
The majority of patients with osteopenia (91.67%) had a 
low risk level for hip fracture; 5.56% of patients with osteo-
Table 1 General characteristics of the study participants
General characteristics Osteoporosis Osteopenia
Number 46 36
Age (years) 66.34±10.23 62.44±7.63
DXA, L1–4
T score
−2.61±1.29a −1.03±1.050a
BMD 1.034±0.84 1.043±0.116a
DXA femur total
T score
−2.38±0.91a −0.90±0.73a
BMD 0.718±0.106 0.892±0.094a
Notes: aStatistically significant difference between the groups (p<0.001). Data 
presented as mean ± SD.
Abbreviations: BMD, bone mineral density; DXA, dual-energy X-ray 
absorptiometry.
Table 2 Difference in representation of fracture risks between patients with osteoporosis and patients with osteopenia (Independent 
Sample t-test)
Fracture risks Disease type N Mean SD t df p-value
Height Osteoporosis 46 161.69 8.39 –0.348 80 0.729
Osteopenia 36 162.28 6.22
Weight Osteoporosis 46 74.33 11.58 –2.250 80 0.027a
Osteopenia 36 68.30 12.39
BMI Osteoporosis 46 27.77 4.57 –1.034 80 0.304
Osteopenia 36 26.43 4.34
Menopause Osteoporosis 46 0.81 0.40 –1.362 80 0.177
Osteopenia 36 0.89 0.32
Previous fractures Osteoporosis 46 0.65 0.48 2.985 80 0.004a
Osteopenia 36 0.33 0.48
Smoking Osteoporosis 46 0.28 0.45 1.231 80 0.222
Osteopenia 36 0.17 0.39
Alcohol Osteoporosis 46 0.065 0.250 –0.731 80 0.467
Osteopenia 36 0.11 0.32
Glucocorticoids Osteoporosis 46 0.065 0.25 0.148 80 0.883
Osteopenia 36 0.057 0.24
Parental history of fracture line Osteoporosis 46 0.239 0.43 –0.393 80 0.695
Osteopenia 36 0.278 0.45
Note: aDifference is statistically significant at 0.05 level. N=sample size; t=t-test scores. Values with significant p-value (<0.05) are bolded.
Abbreviations: BMI, body mass index; df=degrees of freedom.
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penia had a high risk level of hip fracture. Only one patient 
(2.78%) had an intermediate risk level of hip fracture (Table 4).
Discussion
Our study showed that patients suffering from osteopenia 
had a significantly higher fracture risk compared to those 
with osteoporosis, with weight being the contributing risk 
factor. Our results also indicated that patients suffering from 
osteoporosis and who had history of fractures had higher 
fracture risk in comparison to those suffering from osteopenia 
without history of fractures.
It is evident from the extended literature that reduced 
body weight and previous fractures are risk factors for 
lower BMD.23,24 This is consistent with the findings from our 
study, which showed that the average value of body mass 
index (BMI) was 27.77±4.57 kg/m2 among the patients with 
osteoporosis and 26.43±4.34 kg/m2 among the patients with 
osteopenia. Results of previous studies showed that statisti-
cally significant differences in representation of particular 
fracture risks, such as body weight and previous fracture, 
were determined between patients with osteoporosis and 
those with osteopenia.24 Our study revealed that patients suf-
fering from osteopenia had a higher fracture risk compared 
to those suffering from osteoporosis, because of the lower 
body weight, whereas patients suffering from osteoporosis 
had a higher fracture risk because of previous fractures when 
compared to patients suffering from osteopenia. These find-
ings are consistent with those from a previous research, which 
has shown that reduced BMI significantly affects the occur-
rence of osteoporotic fractures,23 and from another study,25 
which suggested that patients with existing fracture due to 
osteoporosis have five times the risk of fracture compared 
to those with no history of fracture.
Our results showed significant difference in average means 
of fracture risk of the hip between patients with osteoporosis 
and those with osteopenia. Patients suffering from osteopo-
rosis were found to have a significantly higher risk of hip 
fracture. This is consistent with reports by Cummings et al25 
that BMD of the hip is a stronger predictor of hip fracture 
than measurements of BMD of other areas of the skeleton.26
Data relevant for FRAX index were given for 46 patients 
with osteoporosis. The low risk of MOF was reported in 
more  number of patients (27 [58.70%]) than intermedi-
ate (14 [30.43%]) and high of MOF (5 [10.87%]). With 
regard to hip fracture, the low fracture risk is reported in 
more number of patients with osteoporosis (26 [56.52%]) 
, than high (17 [39.96%]) and intermediate fracture risks 
(3 [10.00%]).
In our study, we found that the majority of patients with 
osteopenia had low risk level for MOF (23 [63.89%]), with 
only 13 (36.11%) with intermediate risk, while the patients 
(33 [91.67%]) with high risk were not accounted for. In 
addition, the majority of patients with osteopenia had low 
risk level for hip fracture, with only one patient (2.78%) at 
an intermediate risk level and two (5.56%) at a high risk. 
This is contrary to findings from a previous study,27 where 
hip fracture was found to be the most common among 
the patients with high level of risk (74.2%), which clearly 
indicates insufficient recognition of clinical risk factors 
pertinent to fracture occurrence. Findings from this study 
would be useful to public health researchers, policy makers, 
and program managers, in an effort to monitor and design 
programs and community-based interventional strategies 
aimed at reducing the risk of osteoporosis and osteopenia 
in Serbia and surrounding regions and to contribute to the 
global fight against osteoporotic bone fracture.
Table 3 Degree of fracture risk for major osteoporotic fracture and hip fracture for patients with osteoporosis
Fracture type Risk level
Low Intermediate High All
N % N % N % N %
Major osteoporosis 27 58.70 14 30.43 5 10.87 46 100
Hip 26 52.56 3 6.52 17 39.96 46 100
Table 4 Degree of fracture risk for major osteoporotic fracture and hip fracture for patients with osteopenia
Fracture type Risk level
Low Intermediate High All
N % N % N % N %
Major osteoporosis 23 63.89 13 36.11 – – 36 100
Hip 33 91.67 1 2.78 2 5.56 36 100
 
O
pe
n 
Ac
ce
ss
 R
he
um
at
ol
og
y:
 R
es
ea
rc
h 
an
d 
Re
vie
ws
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
17
8.
15
3.
20
5.
12
2 
on
 0
1-
Ju
n-
20
18
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Open Access Rheumatology: Research and Reviews 2018:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
65
Fracture risk among osteoporosis and osteopenia patients
Our study was a cross-sectional study and, therefore, it was 
impossible to determine the causality. However, these findings 
provide basis to clinical determination of treatment options 
and allow some perspectives into the risk of fractures between 
patients with osteoporosis and those with osteopenia. Moreover, 
our sample size was relatively small, and while we have had 
some statistically significant results, a larger sample size could 
further confirm these findings. Finally, while this study showed 
that reduced weight can contribute to fracture risk, this is by no 
means a suggestion that overweight and obesity are protective 
of osteoporotic fractures. There is a fine line between healthy 
weight to maintain healthy strong bones and obesity, which can 
also contribute to fracture risk particularly during falls.
Conclusion
Reduced body weight and previous fractures have been 
found to be statistically significant factors in determining 
fracture risk among patients with osteoporosis and those 
with osteopenia. Patients suffering from osteoporosis have 
a higher percentage of major bone fracture, as well as hip 
fracture. These findings may be useful in the future design of 
interventional strategies to prevent and reduce fracture risk. 
Longitudinal studies and larger sample size are needed to 
further confirm these findings in this population.
Disclosure
The authors report no conflicts of interest in this work.
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